LABD News and Press, Direxion Daily S&P Biotech Bear 3X Shares From 03/23/23

2023-03-23 15:37:54 ET Direxion Daily S&P Biotech Bear 3X Shares ( NYSEARCA: LABD ) - $0.2182 . Payable Mar 28; for shareholders of record Mar 22; ex-div Mar 21. For further details see: Direxion Daily S&P Biotech Bear 3X Shares declares quarterly distrib...

2023-03-19 07:43:18 ET Summary Two new Breakout Stocks for Week 12 with better than 10% short-term upside with ETFs and a Dow 30 Pick. Average cumulative returns for 2023 are +37.3% YTD. The Momentum Gauges® continue negative in bear funds from Mar 7th led by BNKD +65.7%. EGO...

2023-03-12 08:03:25 ET Summary Two new Breakout Stocks for Week 11 with better than 10% short-term upside and Dow 30 Picks. Average cumulative returns for 2023 are +37.6% YTD. The Momentum Gauges® continued negative with bear funds in the Active ETF with over 17% gains this w...

Summary Leveraged ETFs may be unpredictable. A drift dashboard with 22 of them. A closer look at Direxion Daily S&P 500 Bull 3x Shares ETF history. The ProShares Direxion Daily S&P 500 Bull 3x Shares ETF ( SPXL ) is one of the most popular instruments to trade ...

Summary Some explanations about leveraged ETFs’ non-linear behavior. Leveraged ETFs in biotechnology and semiconductors show large drifts. SPXS 12-month drift became negative in April 2022 and has deteriorated since then. Lessons of SPXS history. This article ...

Summary A table with the drifts of SDS and 21 other leveraged ETFs. Biotechnology leveraged ETFs have the worst monthly decay. The annual decay of SDS is close to zero on average, but it may be harmful for long periods of time. The ProShares UltraShort S&P 500 ETF ( ...

Summary Since July 8 when I rated LABD a SELL, the underlying biotechnology index has moved very little up or down; LABD declined 25.22%. The biotechnology sector has done relatively well during the last four months; it is expected to continue trading sideways. The 3x inverse ...

Summary Leveraged ETFs have a non-linear, unpredictable behavior. A drift dashboard with 22 of them. A closer look at one or the worst: LABD. For further details see: LABD: A Bad Bad Drift

Summary LABU is more volatile than unleveraged funds, due to its 3-times investments in the derivatives of stocks listed in its benchmark index. During the past 4 months, biotechnology stocks performed quite well, and this bull run has come during a period when the overall market ...

Summary Leveraged ETFs behavior is neither intuitive nor predictable. Below is a dashboard with 22 of them, including SPUU. LABD is the worst of the list. Focus on SPUU: drift history and comparison with UPRO. The Direxion Daily S&P 500 Bull 2X Shares ETF ( ...